Search Results - "Bukkapatnam, Sanjana"
-
1
Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma
Published in Cancer Immunology, Immunotherapy (01-05-2022)“…Resistance to radiation therapy (RT) remains an obstacle in HPV-negative head and neck squamous cell carcinomas (HNSCCs)—even with a combined RT-immunotherapy…”
Get full text
Journal Article -
2
EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment
Published in Nature communications (20-06-2022)“…Differential outcomes of EphB4-ephrinB2 signaling offers formidable challenge for the development of cancer therapeutics. Here, we interrogate the effects of…”
Get full text
Journal Article -
3
Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma
Published in Cancer cell international (29-03-2017)“…Medulloblastoma is one of the most common types of pediatric brain tumor characterized by the subpopulation of cells that exhibit high invasive potential and…”
Get full text
Journal Article -
4
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration
Published in Clinical cancer research (01-11-2018)“…Radiotherapy (RT) can transform the immune landscape and render poorly immunogenic tumors sensitive to PD-L1 inhibition. Here, we established that the response…”
Get full text
Journal Article -
5
Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers
Published in Clinical cancer research (15-09-2018)“…The clinical success of targeted therapies such as cetuximab and radiotherapy (RT) is hampered by the low response rates and development of therapeutic…”
Get full text
Journal Article -
6
Abstract 5035: Blockade of EphB4-ephrin-B2 interaction remodels the tumor immune microenvironment in head and neck cancers
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Introduction: Identifying targets in the tumor microenvironment (TME) that act as barriers to an effective anti-tumor immune response has become an…”
Get full text
Journal Article -
7
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor
Published in Molecular cancer therapeutics (01-09-2018)“…Eph proteins have emerged as critical drivers affecting tumor growth and progression in human malignancies. Our The Cancer Genome Atlas (TCGA) data analysis…”
Get full text
Journal Article -
8
Abstract 2946: Role of EphB3 receptor in mediating head and neck tumor growth, cell migration, and response to PI3K inhibitor
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Introduction: Eph proteins have emerged as critical drivers affecting tumor growth and progression in human malignancies. Dysregulated expression of…”
Get full text
Journal Article -
9
Abstract 4169: Inhibition of EphB4-ephrin-B2 signaling results in enhanced sensitivity to cetuximab-radiation therapy in head and neck cancers
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Introduction: The management of locally-advanced head and neck cancer patients relies on the combination treatment involving 7 weeks of radiation…”
Get full text
Journal Article -
10
The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme
Published in Molecular carcinogenesis (01-09-2020)“…The aggressive nature of glioblastoma multiforme (GBM) may be attributed to the dysregulation of pathways driving both proliferation and invasion. EphrinB2, a…”
Get full text
Journal Article -
11
Abstract 4173: Inhibition of EphB4-ephrinB2 signaling increases efficacy of radiation in pancreatic ductal adenocarcinoma
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Introduction: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related death in the United States. Survival rates are…”
Get full text
Journal Article -
12
Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC
Published in Cell reports. Medicine (15-08-2023)“…The implementation of cancer immunotherapies has seen limited clinical success in head and neck squamous cell carcinoma (HNSCC). Interleukin-2 (IL-2), which…”
Get full text
Journal Article -
13
Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs
Published in Med (New York, N.Y. : Online) (08-03-2024)“…Perineural invasion (PNI) and nerve density within the tumor microenvironment (TME) have long been associated with worse outcomes in head and neck squamous…”
Get more information
Journal Article